Literature DB >> 9007855

The surgical resectability of meningiomas of the cavernous sinus.

M G O'Sullivan1, H R van Loveren, J M Tew.   

Abstract

OBJECTIVE: The optimal management for patients with cavernous sinus meningiomas remains controversial. We attempt to contribute to the ongoing debate of appropriate surgical indications.
METHODS: In this retrospective review, 39 patients, including 27 women and 12 men ranging in age from 24 to 73 years (median, 48 yr), underwent surgical treatment for this condition. Completeness of tumor resection, cranial nerve morbidity, general morbidity, and long-term outcome were studied. The cavernous internal carotid artery was partially encased in 15 patients, totally encased in 11 patients, and narrowed by tumor in 13 patients.
RESULTS: Of eight patients who underwent complete tumor resection, seven had partial encasement of the internal carotid artery. Of 31 patients who underwent subtotal resection, 11 underwent postoperative radiotherapy. There were no deaths in the series. Morbidity was 17.9% for cranial nerves controlling extraocular motor function. Trigeminal nerve function did not improve after surgical treatment. The median follow-up period was 2 years (range, 6 mo-5.3 yr). Symptomatic and radiographic recurrence occurred in two patients who underwent complete tumor resection and in two patients who underwent subtotal resection.
CONCLUSION: Based on our findings and a review of the literature, we conclude the following: 1) the resectability of meningiomas of the cavernous sinus depends on the degree of internal carotid artery involvement; 2) total excision of cavernous sinus meningiomas is possible but rarely achieved in holocavernous meningiomas; 3) cranial nerve morbidity is significant; and 4) subtotal excision with or without postoperative radiotherapy is an effective short-term oncological strategy.

Entities:  

Mesh:

Year:  1997        PMID: 9007855

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  31 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

Review 2.  Stereotactic radiosurgery for benign meningiomas.

Authors:  Orin Bloch; Gurvinder Kaur; Brian J Jian; Andrew T Parsa; Igor J Barani
Journal:  J Neurooncol       Date:  2011-10-18       Impact factor: 4.130

Review 3.  Trigeminal complications arising after surgery of cranial base meningiomas.

Authors:  Ulf Westerlund; Bengt Linderoth; Tiit Mathiesen
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

Review 4.  Skull base surgery for benign skull base tumors.

Authors:  Ketan R Bulsara; Ossama Al-Mefty
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

Review 5.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

6.  Skull Base Meningiomas and Cranial Nerves Contrast Using Sodium Fluorescein: A New Application of an Old Tool.

Authors:  Carlos Eduardo da Silva; Vinicius Duval da Silva; Jefferson Luis Braga da Silva
Journal:  J Neurol Surg B Skull Base       Date:  2014-04-17

7.  Lateral transorbital neuroendoscopic approach to the lateral cavernous sinus.

Authors:  Randall A Bly; Rohan Ramakrishna; Manuel Ferreira; Kris S Moe
Journal:  J Neurol Surg B Skull Base       Date:  2013-09-09

Review 8.  Contemporary surgical outcome for skull base meningiomas.

Authors:  Chien-Min Chen; Abel Po-Hao Huang; Lu-Ting Kuo; Yong-Kwang Tu
Journal:  Neurosurg Rev       Date:  2011-05-26       Impact factor: 3.042

9.  Patterns of failure after stereotactic radiotherapy of intracranial meningioma.

Authors:  Vasileios Askoxylakis; Angelika Zabel-du Bois; Wolfgang Schlegel; Jürgen Debus; Peter Huber; Stefanie Milker-Zabel
Journal:  J Neurooncol       Date:  2009-12-13       Impact factor: 4.130

10.  Use of sodium fluorescein in skull base tumors.

Authors:  Carlos Eduardo da Silva; Jefferson Luis Braga da Silva; Vinicius Duval da Silva
Journal:  Surg Neurol Int       Date:  2010-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.